| Value | ₹1.25 Cr |
|---|
BSE filing, NSE: GENNEX. Summary written from the filing by ALFA Finder's alert engine.
Gennex Laboratories Ltd: key numbers
- Share price
- ₹8.96
- Market cap
- ₹217.7 Cr
- Revenue (annual)
- ₹172.7 Cr
- Net profit (annual)
- ₹20.98 Cr
- P/E (TTM)
- 9.2×Sector 48.7×
- Promoter holding
- 23.63%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gennex Laboratories Ltd
All →Gennex Laboratories Other Announcement
Gennex Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Gennex Laboratories Management Change
Gennex Laboratories announced the appointment of Mr. Dipankar Dasgupta as Independent Director, replacing Mr. Amudala Sreeramulu Nageswar Rao, effective October 1, 2026.
Gennex Laboratories Annual General Meeting
Gennex Laboratories Limited held its 41st electronic Annual General Meeting on September 30, 2026. Proceedings included the adoption of financial statements and appointment of company directors.
Gennex Laboratories Business Update
Subsidiary Deccan Remedies Ltd received approvals from the Drug Control Administration, Andhra Pradesh, to manufacture ten additional pharmaceutical products and test licences at its facility.
Gennex Laboratories Annual General Meeting
Gennex Laboratories Limited announced the closure of its register of members from September 23 to September 30, 2026. This is for the upcoming 41st Annual General Meeting.
Gennex Laboratories Board Meeting Outcome
Gennex Laboratories announced the outcome of its board meeting, approving the draft directors' report and scheduling the 41st Annual General Meeting for September 30, 2026.
Other share pledge announcements
All →Ginni Filaments Share Pledge
SBICAP Trustee released a pledge over 26,48,300 Ginni Filaments shares, cutting its stake to 9.06%. No cash changed hands in the encumbrance release.
Manipal Health Enterprises Share Pledge
Promoter entity MEMG International India Pvt Ltd released pledges over 72,50,000 and 72,42,951 shares of Manipal Health Enterprises. The 22 October 2026 release eases encumbrances in favour of Vistra ITCL and 360 One Prime.
Camlin Fine Sciences Share Pledge
Camlin Fine Sciences promoter-director Ashish Dandekar created pledges over 13.60 lakh shares worth ₹11.39 Cr. No change in shareholding; total pledged exposure rises for investors to monitor.
- Value
- ₹11.39 Cr
TVS Holdings Share Pledge
Promoter trusts pledged TVS Holdings shares to JM Financial entities as security for credit facilities. The pledge covers 16,75,800 shares, or 8.28% of total share capital.
Paisalo Digital Share Pledge
Equilibrated Venture Cflow, a promoter group entity, pledged 2.98 crore Paisalo shares on October 26, 2026. The pledge secures a Rs.25 Crore third-party loan from Jio Credit.
- Value
- ₹25.00 Cr
Paisalo Digital Share Pledge
Promoter group entity Equilibrated Venture Cflow pledged 1,03,63,523 shares, valued at Rs.79.59 Crore, on October 26, 2026. Promoter holding stays at 20.64% after the pledge.
- Value
- ₹79.59 Cr